New Statins (Cholesterol & Cardio) treatments in trials
Atorvastatin, Rosuvastatin, Simvastatin — lipid-lowering & cholesterol control. Track the treatments still in clinical testing and see which are closest to an FDA decision.
141 statins (cholesterol & cardio) trials are recruiting right now, 15 of them in Phase 3 — the stage immediately before an FDA decision.
Recruiting now
Twelve of the currently recruiting studies. Open one for a plain-English summary of who it is for and what it involves.
Already approved for this area
HMG-CoA Reductase Inhibitors (Statins)
Lipitor, Crestor, Zocor, Pravachol — approved products with their NDC records and billing codes.
Every NDC in this class
The FDA registry filtered to hmg-coa reductase inhibitors (statins), with packaging and 11-digit billing conversions.
Loading the trial explorer…